Baylor
The Medical Genetic Multiomics Laboratory recently launched its first diagnostic test, a whole-transcriptome RNA-seq assay, commercialized by Baylor Genetics.
Baylor Genetics, Baylor College of Medicine Launch Joint Diagnostics Lab Venture
The new lab has also launched a transcriptomic sequencing test aimed at identifying disease-causing genes from blood and skin cells.
The AI assistant has been trained on a knowledgebase made up of the latest Clinical Pharmacogenetics Implementation Consortium data for statins.
New Data in Kidney Cancer Bolsters Promise of Mass Spec Technique for Assessing Surgical Margins
Premium
Investigators hope they can establish the technology in kidney cancer and other tumor types to improve surgery success and associated survival outcomes.
Pediatric Patients Face Barriers Receiving Exome Sequencing From Insurance, Scheduling Delays
Premium
A recent analysis found that it can take between five days and more than a year from when testing is first considered to sample collection.
Apr 13, 2022
Apr 25, 2019
Nov 9, 2017